The REACT-2 trial compared the effectiveness of two treatment algorithms, enhanced care or step-care, to reduce the risk of Crohn’s disease related complications at 2 years. In this touchIMMUNOLOGY interview, we speak with Dr Vipul Jairath (Western University, University Hospital, London, ON, Canada) to discuss the REACT-2 trial and future studies. The abstract entitled ‘A […]